Product Information
KEPPRA 100 MG/ML ORAL SOLN is a brand product labeled by UCB, Inc., priced at $1.9186 per ML under NDC 50474000148. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the levetiracetam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/mL
Manufacturer
UCB, Inc.NDC
50474000148
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVETIRACETAMApproval Type
New Drug (NDA)
FDA Application
NDA021505On Market Since
10/20/2003
Pharmacological Classes
Price Statistics
The NADAC for KEPPRA 100 MG/ML ORAL SOLN has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9186 per ML |
|---|---|
| All-time high | $1.9234 (May 13, 2026) |
| All-time low | $1.0657 (Dec 18, 2013) |
| 52-week high | $1.9234 |
| 52-week low | $1.8746 |
| Median price | $1.4967 |
| Average price | $1.5376 |
| Largest weekly change | +9.9% (Jan 8, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KEPPRA 100 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for KEPPRA 100 MG/ML ORAL SOLN, manufactured by UCB, Inc., is $1.9186 per ML (NDC 50474000148), effective Jun 24, 2026.
How has the price of KEPPRA 100 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for KEPPRA 100 MG/ML ORAL SOLN has risen 78.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KEPPRA 100 MG/ML ORAL SOLN?
Since Nov 28, 2013, the NADAC for KEPPRA 100 MG/ML ORAL SOLN has ranged from a low of $1.0657 (Dec 18, 2013) to a high of $1.9234 (May 13, 2026), with a median of $1.4967 per ML.
Are there cheaper alternatives to KEPPRA 100 MG/ML ORAL SOLN?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVETIRACETAM 100 MG/ML SOLN, is $0.0301 per ML — about 98% below KEPPRA 100 MG/ML ORAL SOLN.
Who manufactures KEPPRA 100 MG/ML ORAL SOLN?
KEPPRA 100 MG/ML ORAL SOLN (NDC 50474000148) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification